Senior Clinical Scientist, Immunology jobs in United States
cer-icon
Apply on Employer Site
company-logo

TRexBio · 1 day ago

Senior Clinical Scientist, Immunology

TRexBio is a clinical stage biotechnology company focused on developing therapeutics for inflammatory diseases. The Senior Clinical Scientist will support clinical development planning and contribute to the design and execution of early phase clinical trials, collaborating with cross-functional teams to ensure successful trial outcomes.

BioinformaticsBiopharmaBiotechnology

Responsibilities

Support clinical development planning via assessment of unmet need, scientific data, regulatory landscape, and expertise in innovative trial design, methodology, and outcome measures
Contribute to design of early phase (Ph1-2) clinical trials, together with cross functional experts
Serve as a key author for clinical trial protocols, informed consent forms, relevant parts of investigators brochure, clinical documents for regulatory submissions including IND and CTAs, and other clinical trial documents
Coordinate cross functional reviews of clinical documents in collaboration with clinical operations leader
Review regulatory documents in collaboration with regulatory leader
Create presentations for clinical trial sites and advisory board meetings
Monitor clinical trial data during study conduct
Provide input to clinical trial data interpretation
In coordination with clinical operations leader, liaise with clinical trial site staff and clinical research organization
Contribute to authoring of clinical study reports
Collaborate with all study team members including Clinical, Medical, Clinical Operations, Drug Safety, Regulatory Affairs, Clinical Pharmacology, Toxicology and CROs

Qualification

Clinical research experienceImmunology expertiseGCP/ICH knowledgeClinical trial designMedical writing skillsData interpretationPharmacology knowledgeMicrosoft Office proficiencyCommunication skillsTeamworkProblem-solving skillsDetail-orientedInitiative

Required

10+ years of experience in clinical science, clinical research, or equivalent in the biopharmaceutical industry
Advance Degree in Clinical or Life Sciences (Pharm D, PhD, MD)
Proficient knowledge of GCP/ICH, drug development process, study design, statistics, pharmacology, clinical operations, early phase clinical research
Proficient knowledge and skills to support data review, trend identification, data interpretation
Excellent verbal, written, communication and interpersonal skills
Must be able to effectively communicate and collaborate
Ability to assimilate technical information quickly
Routinely takes initiative
Detail-oriented
Strong sense of teamwork; ability to lead team activities
Proficient in medical terminology and medical writing skills
Knowledge of or proven ability to gain knowledge of relevant disease area(s), KOLs, indication(s), compound(s) under study (including MOA, PK/PD, biomarker & safety profile)
Proficient critical thinking, problem-solving, decision-making skills
Understanding of functional areas and cross-functional relationships
Commitment to Quality
Willing and able to adjust to multiple demands and shifting priorities as well as an ability to meet day-to-day challenges with confidence and professionalism
Ability to develop short to mid-range plans that are realistic and effective in meeting goals
Proficient in Microsoft Word, Excel, PowerPoint, and clinical trial data reporting tools
Embraces and supports a start-up, small biotech work culture including innovation, resourcefulness, agility, and teamwork
Domestic and International travel may be required (up to 25%)

Preferred

Expertise in Immunology and biologics medicines development for immune mediated diseases preferred

Benefits

Discretionary Bonus

Company

TRexBio

twittertwitter
company-logo
TRexBio is a clinical-stage biotechnology company discovering and developing immunoregulatory medicines based on tissue Treg biology by leveraging cutting-edge computational biology tools, a focus on human tissue, and deep immunobiology expertise.

Funding

Current Stage
Growth Stage
Total Funding
$169M
Key Investors
Delos CapitalPolaris Partners
2024-11-13Series B· $84M
2022-03-08Series A· $26M
2021-06-22Series A· $59M

Leadership Team

leader-logo
Johnston Erwin
Chief Executive Officer
linkedin
Company data provided by crunchbase